Trademarkia Logo

Canada

C$
DUXXIBEL
FORMALIZED

on 26 Sept 2024

Last Applicant/ Owned by

Anthos Therapeutics, Inc.

101 Main Street, Suite 1210Cambridge MA 02142

US

Serial Number

2352203 filed on 12th Aug 2024

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

DUXXIBEL

Trademark usage description

pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and associated disorders; pharmaceutical preparations for the Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and associated disorders; pharmaceutical preparations for the treatment of cancer-associated diseases and disorders.


Classification kind code

12

Mark Details


Serial Number

2352203

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 13th Dec 2024
Agent Changed
Submitted for opposition 257
on 26th Sept 2024
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 26th Sept 2024
Formalized
Submitted for opposition 1
on 26th Sept 2024
Created
Submitted for opposition 30
on 12th Aug 2024
Filed
Submitted for opposition 228
on 12th Aug 2024
International Registration